Canagliflozin Targeting Vascular Inflammation (NCT05427084)
Canagliflozin Targeting Vascular Inflammation: An Ottawa Imaging Study - A Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
CANTOR SING is a pilot single center double blinded randomized study. The investigators will compare the effect of canagliflozin (300 mg daily - intervention arm) vs. placebo (control group) on the FDG aortic uptake in patients with stable CAD (over 60 days post-myocardial infarction) after a 6-month period of treatment. The investigators plan to enroll 8 patients in each arm (total sample size: 16 patients). Primary endpoint is the change in FDG aortic uptake between baseline and 6 months in each arm.
Who can join: Review the eligibility criteria below.
Location: University of Ottawa Heart Institute — Ottawa, Ontario
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Ottawa Heart Institute — Ottawa, Ontario
📞 Contact the Study Coordinator
Phone: (613) 696-7000
Email: kboczar@ottawaheart.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Type 2
- Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees — Boston, Massachusetts
- Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes — Portage la Prairie, Manitoba
- Enhancing Diabetes Care by Treating Insomnia — Zachary, Louisiana
- Metformin Effects According to SLC16A11 Carrier Status — Mexico City, Mexico City
- Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life — New Haven, Connecticut
Explore by condition: All Diabetes Type 2 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.